Alessandro Maselli, Catalent CEO (Adrien Villez for Endpoints News)
April 5, 2024 04:18 PM EDT
Deals
Manufacturing

Catal­ent had sev­er­al suit­ors, in­clud­ing an­oth­er of its busi­ness part­ners, be­fore No­vo won out

Kyle LaHucik

Senior Reporter

In 2022, about nine months be­fore No­vo Hold­ings first reached out to Catal­ent about a po­ten­tial deal, the con­tract man­u­fac­tur­er was in talks with an­oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

No­vo Nordisk to phase out its pro­duc­tion of hu­man in­sulin pens glob­al­ly

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times